Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
07/04/2026 12:29
April 7 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O: KIORA PHARMACEUTICALS INC - ENTERS SECURITIES PURCHASE AGREEMENT ON APRIL 3, 2026 - SEC FILING KIORA PHARMACEUTICALS INC - TO ISSUE 438,471 SHARES OF COMMON STOCK IN PRIVATE PLACEMENT - SEC FILING Further company coverage: KPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing